Advertising Policies

Advertising and commercially sponsored publications do not influence editorial decisions. Pathogenesis and Treatment in Stroke (Abbreviated as PTS) will not endorse any product or service indicative of an advisement or promoted by a sponsor in its own publications and the editorial content will not be bound by commercial or financial interests, or by any specific arrangements with advertisers or sponsors.

Any type of advertisements with potential concerns about damages to PTS’s brand and inappropriateness to the content on its website would be declined.

Any advertisements involved products or services exerting detrimental effects on health (e.g.,. tobacco and alcohol products) are not accepted in PTS.

Any cheating, misleading or exaggerated contents being further from the truth may not appear in advertisements. Clear identification of the advertiser and the product, service being offered with trademark or signature should be made in advertisements. Any indecent or offensive contents appearing in either text or artwork of advertisements or any discrimination of individual privacy, race, religion, or sex appearing in advertisements will not be accepted.

Advertising should always be separated from content in articles published in PTS. The advertising regarding specific treatments or drugs may not be allowed to link to any page of published articles for promotional purposes. That means it is unavailable for readers to find advertising information when reading articles, even searching relevant key words.

Correct and rational use without misleading should be greatly recommended in these advertisements for specific drugs, which fully comply with the specific countries’ legislation that regulates advertising. For these advertisers, the relevant marketing authorization and summary of product characteristics should be offered to PTS at the time of submitting their advertisement . To be specific, the full generic name of each active ingredient should be clearly described in the contents of drug advertisements. Identification information of a prescription-only medicine should be made on each page of such advertisement for health professionals’ reference.

In the context that there should be a discrepancy between advertisements and editorial content, “Advertorial” content is not applicable to publish in PTS, so as the sponsored supplements. A clear statement should always be made once no peer review process was performed, or such process was different from the rest of the journal in a supplement.

Journal editors have the sole right to make decisions where current or potential sponsors and advertisers as well as marketing decisions are inapplicable. Search results are based solely on the functionality available through our search software and user-defined criteria (e.g.,. keyword or topic )rather than special settings from advertisers and sponsors.

The advertisement deployed online will be withdrawn from the journal site at any time as requested by the Editor(s)-in-Chief or Publisher.

A request should always be made to editorial office once additional advertising positions are required beyond PTS standards. Response to such request with a full and final decision will be made within two business days.

Any complaints regarding advertisements will be presented in the Advertisements page.

If you have any complaints about advertising, please feel free to contact us by Advertising@exploverpub.com